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This research utilized the Pichia pastoris expression system for recombinant expression of cDNA of pleurocidin, a small (2.7kd)
antimicrobial peptide isolated from winter ﬂounder (Pleuronectes americanus). The Pichia vector contains the alcohol oxidase gene
promoter (AOX 1), which under the induction of methanol allows for expression of heterologous protein gene inserted downstream
in the vector. Two strains of Pp a s t o r i swere used as host cells, the wild type (Pp a s t o r i sX-33(mut+))a n dt h em u t a n t( P pasatoris
KM71H(muts)). Polymerase chain reaction (PCR) and DNA sequencing showed that pleurocidin cDNA was successfully integrated
into the Pp a s t o r i sgenome. Reverse transcription (RT)-PCR showed that pleurocidin was transcribed by both Pichia host strains.
Aﬃnity chromatography, SDS-PAGE, and immunological techniques were used for puriﬁcation and detection of recombinant pep-
tide. Although there was strong evidence of transcription of pleurocidin cDNA, the Pichia system requires further optimization to
obtain detectable levels of this small peptide.
INTRODUCTION
Pleurocidin is a 25-amino-acid peptide isolated from
the skin mucus secretions of the winter ﬂounder (Pleu-
ronectes americanus) (Cole et al [1]). Pleurocidin exhibits
broad-spectrum antimicrobial activity, is salt- and heat-
tolerant, and is also noncytotoxic and nonhemolytic to
human cells in vitro (Cole et al [1]; Burrowes et al [2]).
Pleurocidinhasbeenfoundtobeeﬀectiveagainstclin-
ical isolates from patients with urinary and respiratory
tract infections and hip and bone wounds, and acts syner-
gistically with D-cycloserine against the food-related and
medically signiﬁcant Mycobacterium tuberculosis (Cole et
al [3]). The amide structure of pleurocidin was found
to reduce the mortality of coho salmon infected with
Vibrio anguillarum and to be more eﬀective against some
ﬁsh pathogens than gramicidin S and polymyxin B (Jia
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et al [4]). These ﬁndings suggest that pleurocidin has po-
tential application in aquaculture, as well as for food and
pharmaceutical applications.
The high cost of chemically synthesizing pleurocidin
or isolating it directly from the winter ﬂounder is pro-
hibitive forthelarge-scaleapplications. However,produc-
ing the peptide in a microbiological system through the
use of a genetically modiﬁed organism would allow for
large-scale production and puriﬁcation.
Pichia pastoris is a methylotropic yeast capable of uti-
lizing methanol as a sole carbon source. The AOX 1 pro-
moter, which regulates the AOX 1 gene allows for the pro-
ductionofthealcoholoxidaseenzymerequiredfortheox-
idationofmethanolandalsoallowsfortheoverexpression
of heterologous protein genes introduced downstream in
a Pichia expression vector. This allows for the produc-
tionof10–100timesmorerecombinantproteinthandoes
the traditionally utilized Saccharomyces cerevisiae expres-
sion system (Higgins and Cregg [5]). Methanol induced
Pp a s t o r i scultures grown in shake-ﬂask results in expres-
sion levels of approximately 5% of total soluble proteins.
However, this level is increased to > 30% of total pro-
teinsincellsgrowninfermenterculturesutilizinggrowth-
limiting rates of methanol. A key factor is the preferential
use of the Pp a s t o r i ssystem for respiratory growth, which
facilitates its culturing at high-cell densities relative to fer-
mentation yeasts such as Saccharomyces cerevisiae (Hig-
gins and Cregg [5]; d’Anjou and Daugulis [6]; Villate et2005:4 (2005) Cloning of Pleurocidin cDNA in Pichia pastoris Vectors 375
al [7]). The Pp a s t o r i sexpression system allows for the re-
combinantproteintoeitherbeexpressedintracellularlyor
to be secreted into the growth medium. Secretion is said
to be the ﬁrst step in puriﬁcation of heterologous proteins
produced from the Pichia system because it separates the
recombinantproteinfromthebulkofthecellularproteins
whicharepresentinlowconcentrationsinPichiacells(El-
dinetal[8];HigginsandCregg[5];Shenetal[9]).Hence,
the recombinant protein will form a major portion of the
total protein in the expression medium.
The Pichia vectors carry the secretion signal sequence
from the Saccharomyces cerevisiae α-factor prepropeptide
located downstream from the AOX 1 promoter and up-
stream from the heterologous protein gene, thus facilitat-
ing secretion of the expressed protein.
The vector used in our studies is the pPICZα vector
designed by Invitrogen Corporation (Invitrogen Corpo-
ration, Calif). This vector contains functional sites which
are designed for ease of integration of foreign protein
genes, selection of transformants, puriﬁcation and iden-
tiﬁcation of the recombinant protein.
Several investigators including Eldin et al [8]a n d
Baumgartner et al [10] have utilized the convenience of
the secretion signal and hexahistidine tag contained in
the Pp a s t o r i svectors to express and purify recombinant
proteins in a one-step puriﬁcation procedure using aﬃn-
ity metal-chelating chromatography. Eldin et al [8]p u -
riﬁed two single-chain antibody fragments, which were
expressed at 250mg/L and 60mg/L, respectively. Baum-
gartner’s group expressed and puriﬁed the kidney bean
lectin phytohemagglutinin E-form, which was secreted in
the expression medium to levels of 16mg/ml. The use of
both the wild-type methanol-utilizing strain Pp a s t o r i sX-
33(mut+) and the slow methanol-utilizing strain Pp a s t o r i s
KM71H (mut−) to express various heterologous proteins
is well documented (Bellevik et al [11]; Ogawa et al [12];
Reddy and Dahms [13]; Baumgartner et al [10]; and Feng
et al [14]).
The objective of this research is to investigate the suit-
ability of the Pp a s t o r i sexpression system as a means of
recombinant expression of pleurocidin. The rationale for
the use of this expression system in our research is based
on the previously outlined features of the Pp a s t o r i sex-
pression system as well as the widely documented success
of previous workers utilizing this system. Other expres-
sion systems such as the the Escherichia coli expression
system was not used in our research because pleurocidin
is being investigated as a potential food preservative, E
coli is perceived as being a dangerous pathogen, therefore
using Ec o l iwould not have been appropriate for the ex-
pression of pleurocidin from a consumer acceptance per-
spective, and therefore using Ec o l iwould not achieve our
objective. However, Pp a s t o r i si si d e a l l ys u i t e da sam e a n s
of producing pleurocidin for human use, because Pichia
cells have been previously used as a source of animal feed
by the Phillips Petroleum Company, and would therefore
be much more acceptable from a consumer standpoint.
Moreover, expression in yeast would allow for the ease of
upscaling from benchtop to large fermentation volumes
that would be required if pleurocidin is to be produced in
suﬃciently large quantities for future commercial use.
It is noted, however, that the majority of reported
studies using the Pichia system have been with relatively
large molecules (20–80kd). A major challenge in our
studies is that we aim to express a small peptide (pleu-
rocidin), which is, indeed, a very small peptide (2.7kd).
MATERIALS AND METHODS
Vectorselectionandcloning
The EasySelect Pichia Expression System was used for
these genetic engineering studies. All primers, vectors,
andhostcellswereobtainedfromInvitrogenCorporation
(Invitrogen Corporation, Calif). The vector (pPICZα),
pleurocidin cDNA (obtained from Dr. Gill Diamond—
UMDNJ), and primers were forwarded to Common-
wealthBiotechnologies Inc (Richmond, Va),wherein col-
laborationwithourlaboratory,thepleurocicincDNAwas
cloned into the pPICZα vectors and returned to our labo-
ratory for transformation and expression experiments.
Two clones were constructed, a native 75 base-pair
pleurocidin fragment (pPICZα A) and a modiﬁed 75
base-pair fragment in which several nucleotides were
changedtomatchthecodonsequencespreferentiallyused
by Pp a s t o r i scell (pPICZα B). The changes made in
pPICZα Bw e r ea sf o l l o w s .
(i) Alanine (19) codon changed from GCG to GCT
(GCG tRNA is rare in Pichia).
(ii)Thesegmentsequencedphenylalanine(5&6)and
lysine (7 & 8) having codons TTT TTT AAA AAA were
modiﬁed to TTC TTC AAG AAG as AT rich regions have
been demonstrated to prematurely terminate transcrip-
tion in Pichia.
(iii) The terminal codons TAC and CTT for tyrosine
and leucine, respectively, were changed to read TAT and
CCT to facilitate direct fusion of the pleurocidin cDNA to
the myc-epitope.
TransformationofPpastorishoststrains
Two strains of Pp a s t o r i scommonly used in hetero-
logus protein expressions were selected for transforma-
tion with the pleurocidin cDNA in our laboratory; Pichia
host cells Pp a s t o r i sX-33(mut+),aw i l dt y p ePichia strain
containing the AOX 1 promoter which allows for rapid
growthwhileutilizingmethanolasthesolecarbonsource;
and KM71H(muts), a mutant strain containing a disrupted
AOX 1 promoter gene resulting in a slow methanol-
utilizing strain. Both cultures were made competent and
transformed in our laboratory by introduction of the lin-
earized pPICZα vectors into these cells using the EasyS-
elect Pichia Expression System. (Invitrogen Corporation,
Calif). Transformed cells were selected by growth on yeast
extract peptone dextrose (YPD) agar plates containing
zeocin (100µg/mL).376 Olive-Jean Burrowes et al 2005:4 (2005)
Preparationofcompetentcells
Pichia host cells were grown in YPD broth overnight
(30◦C/250 RPM) and prepared for transformation with
the pPICZα vector containing the pleurocidin insert, ac-
cording to the manufacturer’s recommendations (Invit-
rogen Corporation, Calif). Competent cells were stored at
−80◦C until the time of transformation.
Transformationbypolyethyleneglycol(PEG)method
The linearized vector containing the pleurocidin
cDNA was added to competent cells and transforma-
tion of Pp a s t o r i shost cells (Pp a s t o r i sX-33(mut+) and
KM71H(muts)) was performed using the PEG method
according to the EasySelect Pichia instruction manual
(Invitrogen Corporation, Calif). Transformants were se-
lected on zeocin-containing medium (YPDS +100µg/mL
zeocin).
Determinationofmethanol-utilizing(mut)
phenotype
In order to determine the length of time required for
expression of recombinant protein by the transformed
Pp a s t o r i shost cells, it is necessary to determine the
methanol utilization (mut) phenotype of the strain. The
mut phenotype for the transformed Pichia X-33 strain
was determined by the procedure outlined in Invitro-
gen’sEasySelectPichiaexpressionmanual.Brieﬂy,growth
of cells on minimal media with dextrose (MDH) was
compared to growth on minimal media using methanol
(MMH) in place of dextrose. The intensity of growth
of test cells was then compared to growth of control
strains Pichia GS115/HSA (muts) which produces al-
bumin (65kd) while slowly metabolizing methanol as
sole carbon source and GS115/LacZ (mut+)w h i c hp r o -
duces β-galactosidase(120kd)whilerapidly metabolizing
methanol as sole carbon source. (mut+)c e l l sg r o wn o r -
mally on both media while (muts)c e l l sg r o wn o r m a l l yo n
minimal media with dextrose but show negligible growth
on minimal media with methanol.
Expressionexperiments
X-33expression
Four isolated transformed colonies from each host
strain were tested for expression of recombinant pleuro-
cidin. Expression experiments were conducted according
to the methods used by Feng et al [14]a n dY a ne ta l[ 15],
based on the procedure outlined in Invitrogen’s Easy Se-
lect Pichia expression manual, with some modiﬁcations.
Aliquots of expression medium were removed (time
points 0, 6, 12, 24, 36, 48, 60, 72, 84, 96 hours) for
Pp a s t o r i sX-33 strain and (0, 24, 48, 72, 96, 120, 144,
168 hours) for the Pp a s t o r i sKM 71H strain. Simultane-
ously, 2 colonies of Pp a s t o r i sGS115/LacZ were used as
(mut+) intracellular expression control and 2 colonies of
GS115/HSA were used as (muts)s e c r e t i o nc o n t r o l .C e l l
pelletandsupernatantwereseparatedandfrozeninliquid
nitrogen and stored at −70◦C for analysis by SDS poly-
acrylamide gel electrophoresis (PAGE) and Western blot.
Preparationofcellpellets
Pelleted, transformed cells were prepared for analy-
sis by mechanically disrupting the cell wall using glass
beads (0.5 microns in diameter) with buﬀer contain-
ing the protease inhibitor phenylmethylsulfonyl ﬂuoride
(PMSF), sodium phosphate buﬀer (pH 7.4), EDTA, and
glycerol (breaking buﬀer); the breaking buﬀer was used to
prevent protein degradation during cell lysis.
Puriﬁcationbyafﬁnitychromatography
Protein analysis (Bradford method) was performed
to determine protein concentration of the transformed
and expression control samples. The puriﬁcation was per-
formedinbatchmodeusinga10-milliliternickel-charged
agaroseaﬃnitychromatographycolumn(InvitrogenCor-
poration, Calif).
SDSPAGEanalyses
Time-pointsamplesoftransformedcellswereconcen-
trated to approximately 30–50% using a Speed-Vac cen-
trifugal concentrator (Savant Instruments Inc, Farming-
dale, NY, USA) and used for electrophoretic analysis and
Western blotting. Both secretion (GS115/HSA) and in-
tracellular (GS115/LacZ) control samples were also ana-
lyzed by SDS PAGE and Western blotting. Electrophoresis
was performed using Bio-Rad’s Mini Protean II Redi-Gel
System(Bio-RadLaboratories,Hercules,Calif).Duplicate
gels were made for electrophoretic analysis of each sam-
ple. One gel was stained for visualization of protein bands
and the other used for Western blot analysis.
WESTERN BLOTTING
(a)Anti-myc-antibody
After separation by SDS-PAGE, protein bands were
transferredto0.2µmPVDFmembraneandproteintrans-
fer allowed to proceed (100 volts for 1h) in 25mM Tris,
192mM glycine, 30% methanol transfer buﬀer (pH 8.3).
Transblotted PVDF membranes were probed with anti-
myc-alkaline phosphatase conjugate antibody, which rec-
ognizes the myc-epitope attached to the heterologus pro-
tein.Colordevelopmentwasperformedusingthealkaline
phosphatase chromogenic substrate conjugate kit. (Bio-
Rad Laboratories, Calif).
(b)Anti-pleurocidinantibody
Concurrent with the use of anti-mycalkaline phos-
phatase conjugate antibody, transblotted PVDF mem-
branes were probed with pleurocidin antisera. Synthetic
pleurocidin was used as control for the pleurocidin an-
tisera. Synthetic pleurocidin (Ple) showed a strong band
on SDS PAGE gel at approximately 3000kd (Figure 7)
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(1:100 dilution) as primary antibody with anti-rabbit
alkaline phosphatase conjugate (1:20,000 dilution) as
secondary antibody (Figure 8). Lanes 1–4 contained
induced-time course samples from each of 2 clones of P
pastoris X-33(mut+) and Pp a s t o r i sKM71H(muts),r e s p e c -
tively.
Two-steppuriﬁcationprocedures
Expression experiments were scaled up (from
1×250mL ﬂasks to 4 ×250mL ﬂasks) in order to provide
greater cell mass for induction, and hence enhancing
the possibility of obtaining detectable expression of
heterologous protein. Induction was conducted using
buﬀered methanol minimal medium (BMMH) instead of
buﬀered methanol complex medium (BMMY).
1%casaminoacidwasaddedtothemediumtoinhibit
any possible activity of extra cellular proteases. The ex-
pression medium was subjected to dialysis using a 6–8kd
cut-oﬀ dialysis membrane (Spectrum Medical Industries
Inc,Calif).Dialyzedsampleswerethenpuriﬁedbyaﬃnity
chromatography as previously outlined in this paper.
Polymerasechainreaction(PCR)andsequencing
PCR analysis was conducted on transformed cells of
both Pichia strains, in order to conﬁrm whether the pleu-
rocidin cDNA was actually integrated into the P genome.
Four clones, two from each host strain (Pp a s t o r i sX-
33(mut+) and Pp a s t o r i sKM71H(muts))w e r et e s t e da c c o r d -
ing to standard protocol for PCR analysis.
DNA was extracted from cells transformed with the
vector carrying the pleurocidin cDNA, using the Easy
DNA kit for genomic DNA isolation (Invitrogen Corpo-
ration, Calif). PCR products of the extracted DNA were
thenpuriﬁedforsequencingusingQiagen’sQIAquickpu-
riﬁcation kit (Qiagen, Valencia, Calif).
Puriﬁed PCR fragments were sequenced (Biotechnol-
ogy Center, Plant Science Department, Rutgers Univer-
sity) in order to ascertain orientation of inserted cDNA
into the Pichia host cell genome, as well as to reveal
whether there were any mutations in the inserted frag-
ment.
RNAextractionandreversetranscription
Time-point expression samples of 4 clones, two
each from strains (Pp a s t o r i sX-33(mut+) and Pp a s t o r i s
KM71H(muts)) were tested for transcription of the pleu-
rocidin cDNA by the transformed host strains.
RNAextraction
InordertofacilitatethereleaseofRNAfromthetrans-
formed yeast cells, the cells were subjected to mechanical
disruption using a high-speed bead beater, RNA was ex-
tracted from disrupted cells according to the protocol of
theQiagenRNeasyextractionkit(Qiagen,Calif).Allsam-
ples were subjected to on-column DNase digestion using
the Qiagen RNase free DNase treatment (Qiagen, Cailf)
during RNA isolation. Isolated RNA was used as template
in reverse transcriptase reaction.
RT-PCRanalysiswasconductedintwoparts
(a)cDNAsynthesis
First strand cDNA synthesis was performed using the
SuperScript II RT kit (Invitrogen Corporation, Calif).
Extracted yeast RNA+ reverse transcriptase enzyme us-
ing oligo (dT) primers was tested using RNA without
reverse transcriptase enzyme as control.The cDNA pro-
duced from the RT reaction was then used as template for
ampliﬁcation by PCR.
(b)Polymerasechainreacton(PCR)
PCR reaction was performed as previously men-
tioned. PCR controls included PCR mix without added
cDNA template (negative control), and pPICZa vector
containing gene insert (positive control). Both induced
and uninduced samples were analyzed.
AgarosegelelectrophoresisofPCRproduct
SamplesofPCRpr oductwer eloadedont o1%agar ose
gel for electrophoretic separation (100 volts for 35min).
Separated bands were visualized using ultraviolet light
after staining in ethidium bromide (1µg/mL) in Tris-
acetate-EDTA (TAE) buﬀer (30min).
Analysisoftranscriptionsamples
Samples showing transcription of cDNA in RT-PCR
analysis were puriﬁed by metal-chelating aﬃnity column
chromatography as previously outlined in this paper. Pu-
riﬁed fractions showing a relative increase in protein
concentration were analyzed by SDS PAGE and West-
ern blot. The samples used were either supernatant from
expression medium, uncentrifuged expression medium
(whole broth), or lysate from cell pellets of the expression
medium.
RESULTS AND DISCUSSION
The methanol utilization (mut) phenotype of the
Pichia host strain Pp a s t o r i sX-33 transformed with pleu-
rocidin cDNA was conﬁrmed to be mut+ phenotype as
shown in Figure 1.A l lPp a s t o r i sKM71H strains are muts
phenotype due to their disrupted AOX 1 Promoter, there-
fore it was not necessary to determine the mut phenotype
for this strain.
Initial expression experiments with transformed P
pastoris cells showed that the cells used as expression con-
trol (Pp a s t o r i s /GS115/LacZ (mut+)) did indeed express the
recombinantprotein(β-galactosidase)whichwaspuriﬁed
by the nickel-agarose aﬃnity chromatography column se-
lective for his-tag proteins. Expression of β-galactosidase
wasindicatedbyaproteinbandshownintheﬁrstfraction
(F1) eluted from the aﬃnity column anddetected on SDS378 Olive-Jean Burrowes et al 2005:4 (2005)
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Plate 1 Plate 2
Figure 1.Methanolutilization(mut)phenotypeoftransformed
Pichia pastoris X-33. A represents colony of Pp a s t o r i scontrol
strain Pp a s t o r i s /LacZ/β-galactosidase (mut+) strain. B repre-
sents colony of Pp a s t o r i s /HSA/albumin (muts). Plate (1): mini-
malmediawithdextrose(MMD).Plate(2):minimalmediawith
methanol (MMH).
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Figure 2. SDS PAGE gel of puriﬁed fractions of β-galactosidase
expressed by Pp a s t o r i sGS115/LacZ/mut+ expression control
cells, eluted from aﬃnity column. M represents molecular
weight marker; UB represents unbound fraction. W1–W3 rep-
resent wash fractions; F1–F4 represent eluted fractions. Puriﬁed
recombinant β-galactosidase eluted in fraction 1 (F1) is indi-
cated by band at approximate 124kd.
PAGE at approximately 124kd (Figure 2). Western blot of
the SDS PAGE gel showed the reaction of the myc-epitope
attachedtotherecombinantβ-galactosidasewiththeanti-
myc-antibody (Figure 3). The almost indistinguishable β-
galactosidase band in fraction 2 (F2) on the SDS PAGE gel
was clearly visible on the Western blot indicating the in-
creased sensitivity of the Western blot analysis relative to
the SDS PAGE.
A Western blot analysis representative of the results
obtained from expression experiments of the Pp a s t o r i s
cells transformed with the pleurocidin cDNA is shown in
Figure 4. The lack of visible bands in lanes 1–6 which rep-
resentstime-coursesamples(12,24,48,72,84,96h)from
Pp a s t o r i sX-33 (mut+) induction indicates that there was
no detectable level of recombinant pleurocidin obtained
in these expression experiments. The validity of these ex-
pression experiments was, however, conﬁrmed by the ex-
pression of recombinant β-galactosidase by the Pp a s t o r i s
GS115/LacZ/mut+ control cells (Figure 4,l a n e7 )w h i c h
was conducted simultaneously on the test cells.
The demonstration of the presence of expressed re-
combinant protein by the control samples indicates that
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Figure 3. Western blot obtained from transfer of duplicate
SDS PAGE gel containing puriﬁed fractions of recombinant β-
galactosidaseexpressedbyPpastorisGS115/LacZ/mut+ cells and
showing reaction of the myc-epitope of the recombinant β-
galactosidase with the anti-myc-antibody. Puriﬁed recombinant
β-galactosidase eluted in fractions 1 and 2 (F1 and F2) are in-
dicated by band at approximately 124kd. (F2 band only faintly
shown on SDS PAGE gel).
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Figure 4. Western blot (using the anti-myc-antibody) for time-
course samples of induced transformed Pichia pastoris X-33
cells. UB represents ultra-low marker (peptides). BM represents
broad-rangemarker(proteins).1–6:PpastorisX-33time-course
induced samples. 7: Pp a s t o r i sLacZ expression control (48h).
the procedures used for expression and puriﬁcation are
appropriate for Pp a s t o r i stransformation systems. How-
ever, there was no detection of protein bands on SDS gel
electrophoresis or Western blot analysis for test samples.
Similar results were obtained for the mutated Pp a s t o r i s
KM71H(muts) strain.
Inordertoascertainwhethertheabsenceofdetectable
expression of recombinant pleurocidin was due to lack
of, or incorrect integration of the pleurocidin cDNA into
the Pp a s t o r i shost cell genome, PCR was performed on
the transformed yeast DNA followed by DNA sequenc-
ing. Agarose gel electrophoresis of the PCR product of
transformed Pp a s t o r i scells showed that the vector con-
taining the cDNA of pleurocidin was indeed integrated in
all four clones tested. This is indicated by strong bands
at approximately 590bp in lanes 2–5 of the agarose gel of
the PCR product (Figure 5). These lanes represent trans-
formed samples of both strains of Pp a s t o r i sused in this
study. Lanes 6-7 consist of samples from untransformed2005:4 (2005) Cloning of Pleurocidin cDNA in Pichia pastoris Vectors 379
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Figure 5. PCR analysis of transformed Pichia pastoris cells
showing inserted pleurocidin cDNA at 590bp. M represents
500bp marker. Lanes 2–5 represent transformed DNA (Pp a s -
toris KM71H and X-33). Lanes 6–7 represent control DNA (un-
transformed cells in lanes) indicated by parrallel arrows. Lanes
8–9representvectorDNA(vectorwithandwithoutinsert).Lane
10 represents vector with transformed DNA. Lane 11 represents
PCR control (no DNA) indicated by single arrow. Lanes 13–15
represent yeast DNA.
Pp a s t o ri scells (indicated by parallel arrows). The absence
of visible bands in untransformed cells and presence of
the expected bands (590bp) in the transformed cells ver-
iﬁes the fact that pleurocidin cDNA has been inserted in
the Pichia host cells. Lanes 8–10 consist of the linearized
pPICZα vector carrying the pleurocidin cDNA and the
uncut pPICZα vector without pleurocidin cDNA. Lane
11 indicated by the single arrow consists of the PCR mix
without extracted DNA (negative control). The absence
of a DNA band in lane 11 veriﬁes that there was no DNA
contamination in the PCR samples. Yeast DNA observed
in lanes 12–14 was included in the test to verify that DNA
wasindeedextractedfromtheyeastcellsintheeventthere
were no visible DNA bands from the transformed cells.
DNA sequencing of the puriﬁed PCR product con-
ﬁrmed that the pleurocidin gene sequence was correctly
inserted into the yeast genome. The sequence obtained
from the sequencing chromatogram ﬁle showed that the
start of the alpha-factor sequence (GAT1), the pleurocidin
sequence, myc-epitope, and polyhistidine tag followed in
the correct sequence (Figure 6), as veriﬁed by compari-
sonwiththesequenceobtainedbythedesignersandman-
ufacturers of the vectors (Invitrogen Corporation, Calif)
and (Commonwealth Laboratories, Richmond, Va).
Conﬁrmation of the proper integration of the pleu-
rocidin coding sequence into the Pichia genome en-
couraged further investigations. Subsequent experiments
involved induction of colonies from clones conﬁrmed by
PCRandDNAsequencingtocontainthepleurocicingene
sequence. In addition to using the anti-myc-antibody to
test for the presence of recombinant pleurocidin by these
clones, the more speciﬁc anti-pleurocidin antibody was
introduced at this stage of our research. Synthetic pleu-
rocidin (Ple) was used as control for the pleurocidin an-
tisera and showed a strong band on SDS PAGE gel at
approximately 3000kd (Figure 7) and on Western blot
usingtheanti-pleurocidinantisera(1:100dilution)aspri-
mary antibody with anti-rabbit alkaline phosphatase con-
jugate (1:20,000 dilution) as secondary antibody (Figure
8). Lanes 1–4 contained induced time-course samples
from each of 2 clones of Pp a s t o r i sX-33(mut+) and Pp a s -
toris KM71H(muts). The absence of detectable bands on
both SDS PAGE gel and Western blot further indicated
that there was no detectable level of recombinant pleu-
rocidin either using the anti-myc-antibody or the more
speciﬁc pleurocidin antisera.
Having established the proper orientation of the
cDNA into the Pichia yeast genome, it is evident that
nonexpression of recombinant pleurocidin is not due to
lack of modiﬁcation of the Pichia cells, therefore in or-
der to ascertain whether the lack of detection of expressed
recombinant pleurocidin was due to a transcription re-
lated problem, or whether the gene is actually being tran-
scribed, reverse transcriptase analysis was conducted us-
ing induced and uninduced transformed cells. The re-
sults of the RT-PCR analyses show that the pleurocidn
gene is indeed being transcribed by the Pichia system in
both the slow methanol-utilizing strain (KM71Hmuts)a n d
the wild-type methylotrophic strain (X-33 mut+)o ft r a n s -
formed Pp a s t o ri s . Transcription of the pleurocidin cDNA
wasdemonstratedbythepresenceofDNAbands(590bp)
in lanes 11 and 12 (indicated by arrows) on agarose gel
from the RT-PCR products (Figure 9a). Lanes 11–12 rep-
resent induction samples collected on days 5 and 6 for the
PpastorisKM71muts strain.Figure9brepresentsduplicates
of the samples in Figure 9a, without the reverse transcrip-
tase (RT) enzyme added (no RT control). The absence of
visible bands in the no-RT controls veriﬁes the authen-
ticity of the bands observed in the presence of the RT en-
zyme in Figure 9a. Transcription of the pleurocidin cDNA
on day 3 for two diﬀerent clones of (X-33 mut+) was indi-
cated by DNA bands in lanes 21 and 25 indicated by ar-
rows on agarose gels shown in Figure 10a. Lanes 21 and
25 contain induced samples collected on day 3 for the two
clones. Figure 10b represents the no-RT controls.
The greater intensity of the band observed with the P
pastoris (KM71muts) compared to the band observed for
the Pp a s t o r i s(X-33 mut+) strain indicates that there might
be a greater level of expression by the (KM71muts) strain,
however, the appearance of the band shown at day 3 for
the(X-33 mut+)strainsandday5forthe(KM71muts)strain
conﬁrms that induction does occur much later, and hence
more slowly in the (KM71muts) strain. Figures 11 and 12
showthattheproteinproductionforbothstrainsoftrans-
formed Pp a s t o r i sis inversely proportional to growth, in-
dicating that protein expression occurs in the latter part
of the growth phase of the cells.
This phenomenon could be a possible explanation for
the reports of studies conducted by other investigators
who state that protein expression in Pp a s t o r i sexpression
systems is greatly increased when conducted in continu-
ous fermenter cultures compared to when conducted in
ﬂask (batch) cultures (Koganesawa et al [16]; Reddy and380 Olive-Jean Burrowes et al 2005:4 (2005)
ACATGACTGTTCCTCAGTTCAAGTTGGGCACTTACGAGAAGACCGGTCTTGCTAGATTCT
TAGATTCTAATCAAGAGGATGTCAGANTGCCATTTGCA
AAGGGGATTTCAACTCTCGAGAAAAGAGAGGCTGAAGCTGCA GGC
2TGGGGAAGCTTCTTCAA
GAAGGCTGCTCACGTTGGCAAGCATGTTGGCAAGGCTGCCCTTACTCATTATCTA GAA
3CAAA
AACTCATCTCAGAAGAGGATCTGAATAGCGCCGTCGACCAT
4CATCATCATCATCATTGA
5GTT
TGTAGCCTTAGACATGACTGTTCCTCAGTTCAAGTTGGGCACTTACGAGAAGACCGGTCTTGC
JB-04-TCL sequence exported from chromatogram file
TTTTACGCAACTTGAGAAGATCAAAAAANAACTAATTATTCGAAANGAT
1 GAGATTTCCTT
CAATTTTTACTGCTGTTTTATTCGCAGCATCCTCCGCATTAGCTGCTCCAGTCAACACTA
CAACAGAAGATGAAACGGCACNAATTCCGGCTGAAGCTGTCATCGGTTACTCAGATTTAG
GAAGGGGATTTCAATCTCTCGAGAAAGAGAGGCTGAAGCTGCA GGC
2TGGGGAAGCTTCTTCA
AGAAGGCTGCTCACGTTGGCAAGCATGTTGGCAAGGCTGCCCTTACTCATTATCTA GAA
3CAA
TTGTAGCCTTAGACATGACTGTTCCTCAGTTCAAGTTGGGCACTTACGAGAAGACCGGTCTTG
CTAGATTCTAATCAAGAGGATGTCAGAGTGCCATTTGCA
AAACTCATCTCAGAAGAGGATCTGAATAGCGCCGTCGACCAT
4CATCATCATCATCATTGA
5GT
JB-03-TCL sequence exported from chromatogram file
TTNTACGACAACTTGAGAAGATCAAAAAACAACTAATTATTCGAAACGAT
1 GAGATTTCCT
TCAATTTTTACTGCTGTTTTATTCGCAGCATCCTCCGCATTAGCTGCTCCAGTCAACACT
ACAACAGAAGATGAAACGGCACAAATTCCGGCTGAAGCTGTCATCGGTTACTCAGATTTA
CTGCAGGC
2TGGGGAAGCTTCTTCAAGAAGGCTGCTCACGTTGGCAAGCATGTTGGCAAGGCT
GCCCTTACTCATTATCTA GAA
3CAAAAACTCATCTCAGAAGAGGATCTGAATAGCGCCGTCGA
CCAT4CATCATCATCATCATTGA
5GTTTGTAGCCTTAGACATGACTGTTCCTCAGTTCAAGTTGG
GCACTTACGAGAAGACCGGTCTTGCTAGATTCTAATCAAGAGGATGTCAGAATGCCATTTGCA
TTTTACGACAACTTGAGAAGATCAAAAAACAACTAATTATTCGAAACGAT
1 GAGATTTCCT
TCAATTTTTACTGCTGTTTTATTCGCAGCATCCTCCGCATTAGCTGCTCCAGTCAACACT
ACAACAGAAGATGAAACGGCNCAAATTCNGGCTGAAGCTGTCATCGGTTACTCAGATTTA
GAAGGGGATTTCGATGTTGCTGTTTTGNCATTTTCCAACTCTCTCGAGAAAGAGAGGCTGAAG
JB-01-TCL sequence exported from chromatogram file
TTTTACGACAACTTGNAGAAGATCAAAAAACAACTAATTATTCGAAACGAT
1 GAGATTTCC
TTCAATTTTTACTGCTGTTTTATTCGCAGCATCCTCCGCATTAGCTGCTCCAGTCAACAC
TACAACAGAAGATGAAACGGCACAAATTCNGGCTGAAGCTGTCATCGGTTACTCAGATTT
AATCAAGAGGATGTCAGAGTGCCATTTGCA
JB-02-TCL sequence exported from chromatogram file
AGAAGGGGATTTCGATGTTGCTGTTTTGNCATTTTCCAACAGCACAAATAACGGG
TCGAGAAAGAGAGGCTGAAGCTGCA GGC
2 TGGGGAAGCTTCTTCAAGAAGGCTGCTCACGT
TGGCAAGCATGTTGGCAAGGCTGCCCTTACTCATTATCTA GAA
3CAAAAACTCATCTCAGA
AGAGGATCTGAATAGCGCCGTCGACCAT
4 CATCATCATCATCAT TGA
5 GTTTGTAGCCTTAG
Figure 6. cDNA in ORF of yeast genome for all four clones. GAT1 start of alpha-factor sequence. GGC2 start of pleurocidin sequence.
GAA3 s t a r to fm y c - e p i t o p e .C A T 4 Start of polyhistidine tag. TGA5 stop codon.
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Figure7.SDSpolyacrylamidegelshowingsyntheticpleurocidin
(Ple) band at appx 3000kd.
Dahms [13]). In continuous fermentation systems, cell
growth can be easily monitored, thus allowing growth to
be maintained at the required stage for optimum produc-
tion of protein. On the other hand, in ﬂask cultures where
growth is limited by the level of available nutrients, cells
eventually enter the decline/death phase, and therefore
UM Ple 12 3 4
26.6
16.9
14.4
6.5
3.4
Figure 8. Western blot of synthetic pleurocidin (Ple) using anti-
pleurocidinantibody.1-2:inducedexpresisionsamplesofPichia
pastoris X-33 (days 2 and 4). 3-4: induced expresision samples of
Pp a s t o r i sKM71H (days 4 and 6). UM∗ ultra-low marker (pep-
tide marker). Ple: pleurocidin (100µg/mL).
limit the amount of protein that can be obtained. Despite
this possibility, several investigators have successfully ex-
pressed recombinant proteins in shake ﬂasks, using the P
pastoris system (Villatte et al [7]; Paramasivam et al [17];2005:4 (2005) Cloning of Pleurocidin cDNA in Pichia pastoris Vectors 381
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Figure 9. Transcribed pleurocidin cDNA bands at 590b from transformed KMH 71cells at days 5 and 6 (+RT) and gel containing
transformed KMH 71 cells (−RT); positive control shown in lane 48.
Li et al [18]). Thus, there are other factors to be consid-
ered for the lack of detection of recombinant pleurocidin.
The following set of induction experiments focused
onutilizingthosetransformedcellsshowingtranscription
of the pleurocidin cDNA in the RT-PCR tests. Results of
the isolation, puriﬁcation, and detection procedures uti-
lized for these transformed Pp a s t o r i scells are shown in
Figures 13a and 13b.
There was a strong band (indicated by arrows on
each SDS PAGE gels) indicating the recombinant expres-
sion of β-galactosidase (124kd) on both SDS PAGE gel
and Western blot, for the expression control cells (Pp a s -
toris GS115/LacZ), however, there was still an absence of
detectable recombinant pleurocodin bands from trans-
formed host cells in supernatant, intracellular fraction
and puriﬁed whole broth fractions.
The evidence of expression of recombinant β-
galactosidase by the Pp a s t o r i sGS115/LacZ (mut+) expres-
sion control cells used throughout this research veriﬁes
the suitability of the methods and procedures used in this
research.
Despite the absence of evidence of detectable ex-
pression of recombinant pleurocidin, our research has
demonstrated that pleurocidin cDNA was successfully
integrated into the pPICZα vector and the Pp a s t o r i s
system does allow for transcription of the pleurocidin
cDNA, thus it is evident that RNA is indeed being pro-
duced and the lack of detection stems from a posttran-
scription problem.
Three main reasons are cited for the lack of expres-
sion of biologically active proteins in heterologous sys-
tems. These being host cell lacking components for trans-
lation of recombinant protein, the heterologous protein
being prone to proteolysis as it emerges from translation,
and incomplete or improper folding of heterologous pro-
tein (Butt RT, [19]). Although published information in
theliteratureontheexpressionofsmallbioactivepeptides
like pleurocidin is very limited, it is well documented that
amajorlimitationintheexpressionofsmallmolecules(=
10kd) is low or there is a lack of recombinant expression,
often due to RNA instability (Rai and Padh [20]; Scorer et
al [21]).
Additionally,studiesreportedbySreekrishnaetal[22]
stated that two possible factors which inﬂuence protein
expression in Pichia systems are (i) untranslated regions
in recombinant mRNA and (ii) transcriptional and trans-
lational blocks. In our research, it is evident from the
results of the RT-PCR experiments that mRNA is being
transcribed(Figures9and10).Thusitistheleveloftrans-
lation that is being aﬀected. These results corroborates
previousresearchwhichshowsthattheleveloftranslation
in small peptides is often a hinderance to recombinant ex-
pressionofthesesmallpeptides.Pleurocidinbeingasmall
peptide consisting of only 25 amino acids is likely being
degraded after translation.
The level of synthetic pleurocidin used as control
in SDS PAGE electrophoresis and Western blotting was
approximately 2.5µg (100µg/mL). However, SDS PAGE
analysis of serially diluted synthetic pleurocidin samples
indicate that as little as 325ng of pleurocidin can be de-
tected by electrophoresis. It is evident therefore that if
recombinant pleurocidin was indeed produced, it is be-
low 325ng/mL.
This research is of signiﬁcance because it is the ﬁrst
studyreportedontheutilizationofaeukaryoticsystem(P
pastoris expression vectors) for the heterologous expres-
sion of the small novel antimicrobial peptide pleurocidin.
Since in most cases it is impractical to express small pep-
tides in the native host, continued research is required to
modify existing systems to allow for optimal expression
levels to be achieved.
Considering the advantages of the Pp a s t o r i sexpres-
sion system over other recombinant expression systems,
it would be beneﬁcial to proceed with these optimiza-
tion experiments, rather than change from the Pichia sys-
tem to another expression system. We suggest that in the
cloning for expression of small peptides like pleurocidin,
optimization studies should involve the construction of
Pp a s t o r i svectors with multiple cloning sites to facili-
tate multiple copies of the gene to be integrated into the382 Olive-Jean Burrowes et al 2005:4 (2005)
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Figure 10. M: 250-bp DNA ladder. Lanes 1–6: time course samples of KM71H (clone 1) cells. Lanes 7–12: time course samples of
KM71H( clone 2) cells. Lanes 13–18: time course samples of KM71H (uninduced) cells. Lanes 19–22: time course samples of X-33
(clone 1) cells. Lanes 23–26: time course samples of X-33 (clone 2) cells. Lanes 27–30: time course samples of X-33 (uninduced) cells.
Lanes 31–47: duplicates of KM71H cells without reverse transcriptase enzyme (no RT control). Lanes 49–60: duplicates of X-33 cells
without reverse transcriptase enzyme (no RT control). Lanes 48 & 62 vector with pleurocidin DNA insert (positive control). Lane 61:
PCR Master mix without DNA template (negative control). (a) Transcribed cDNA bands at 590bp from transformed X-33 cells at
day 3 (+RT) and (b) gel containing transformed X-33 cells (−RT); positive control shown in lane 62.
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Figure 11. Protein production relative to growth of Pichia pastoris KM71-H(muts).
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Figure 1 2 .P r o t e i np r o d u c t i o nr e l a t i v et og r o w t ho fPichia pastoris X-33(mut+).
host genome. Multiple integration of foreign genes into a
host genome results in increased frequency of producing
high-copy number transformants, subsequently, resulting
in increased expression levels of recombinant proteins
(Rai and Padh [20]; Scorer et al [21]; Sreekrishna et al
[22]; Yan et al [15]).2005:4 (2005) Cloning of Pleurocidin cDNA in Pichia pastoris Vectors 383
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Figure 13. UM represents ultra-marker (peptides). BM represents broad-range marker (proteins). 1-2: Pp a s t o ri sX-33 induced trans-
formants (day 3). 3: uninduced Pp a s t o r i sX-33 transformants (day 3). 4-5: Pp a s t o r i sKM71 H induced transformants (days 5 and
6). 6: uninduced Pp a s t o r i sKM 71H transformants (day 5). 7: Pp a s t o r i sGS115/LacZ expression control. (a) SDS PAGE gel of time-
course intracellular samples of transformed Pp a s t o r i s(KM71H and X-33) and (b) Western blot of time-course intracellular samples
of transformed Pp a s t o r i s(KM 71H and X-33).
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Figure 14. 1-2: Pichia pastoris X-33 clones 1 & 2 at day 3. 3-4: Pp a s t o r i sKM71H clones at days 5 & 6. 5-6: Pp a s t o r i sLacZ and P
pastoris GS115/HSA (controls). UM represents ultra-low marker (peptides). BM represents broad-range marker (proteins). (a) SDS
PAGE gel from supernatant of transformed Pp a s t o r i s(KM 71H and X-33) and (b) Western blot of supernatant from transformed P
pastoris (KM 71H and X-33).
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